Table 3.
TEAE by preferred term* | All patients n (%) (N = 49) | |
---|---|---|
Any grade | Grade ≥3 | |
Any TEAE | 49 (100) | 45 (92) |
Nonhematologic TEAEs | ||
Diarrhea | 32 (65) | 5 (10) |
Fatigue | 23 (47) | 3 (6) |
Nausea | 23 (47) | 2 (4) |
Upper respiratory tract infection | 19 (39) | 0 |
Dyspnea | 17 (35) | 3 (6) |
Insomnia | 17 (35) | 5 (10) |
Cough | 16 (33) | 0 |
Vomiting | 14 (29) | 3 (6) |
Hypertension | 13 (27) | 8 (16) |
Dyspepsia | 12 (24) | 0 |
Edema peripheral | 12 (24) | 0 |
Headache | 10 (20) | 0 |
Hypocalcemia | 10 (20) | 0 |
Hypokalemia | 10 (20) | 1 (2) |
Sinusitis | 10 (20) | 0 |
Abdominal pain | 9 (18) | 0 |
Hypophosphatemia | 9 (18) | 5 (10) |
Pneumonia | 9 (18) | 6 (12) |
Hyperglycemia | 8 (16) | 3 (6) |
Hypomagnesemia | 8 (16) | 0 |
Influenza | 8 (16) | 3 (6) |
Hematologic TEAEs | ||
Lymphopenia† | 17 (35) | 15 (31) |
Thrombocytopenia‡ | 15 (31) | 4 (8) |
Neutropenia§ | 11 (22) | 6 (12) |
Leukopenia|| | 11 (22) | 6 (12) |
Anemia | 9 (18) | 4 (8) |
TEAEs presented are those occurring in ≥15% of patients for any grade or in ≥10% of patients for grades 3 and 4.
Includes decreased lymphocyte count.
Includes decreased platelet count.
Includes decreased neutrophil count.
||Includes decreased white blood cell count.